Literature DB >> 23890347

Development of renal cell carcinoma (RCC) diagnostics and impact on prognosis.

Kaisa L Sunela1, Eero T Lehtinen, Matti J Kataja, Paula M Kujala, Seppo Soimakallio, Pirkko-Liisa I Kellokumpu-Lehtinen.   

Abstract

OBJECTIVE: To evaluate imaging methods and prognoses between small renal cell carcinomas (RCCs) and larger tumours according to the era of diagnostics. PATIENTS AND METHODS: In all, 784 consecutive patients diagnosed with RCC between 1964 and 1997 at the Pirkanmaa Hospital District in Finland were included. Patients were divided into two groups: tumours of ≤3.0 and >3.0 cm in diameter. Prognosis was analysed according to the era of diagnostics: (i) pre-computed tomography (CT) and pre-ultrasound (US), (ii) US era and (iii) CT era.
RESULTS: Small tumours became more common: in the pre-CT and pre-US era, only 4.4% of tumours were small; however, in the CT era 16% were small tumours. More diagnostic methods were used in studying small tumours. CT proved to be the most reliable method, although it was actually better at diagnosing large tumours. Relapses occurred less frequently among patients with small tumours; more than half of the tumours that developed distant metastases (16.0%) already evinced them at the time of diagnosis. There were no relapses after 14 years of follow-up among small tumours, whereas large tumours relapsed within that time. RCC was the cause of death in 14.9% of patients with small tumours vs 50.7% with large tumours. The best prognosis was among patients with small tumours diagnosed with CT.
CONCLUSION: Among patients with small tumours, prognosis has improved along with better diagnostics, although some showed relapse during a surveillance period of up to 14 years.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  carcinoma; diagnostics; prognosis; renal cell

Mesh:

Year:  2013        PMID: 23890347     DOI: 10.1111/bju.12242

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  9 in total

1.  Dynamic changes of different phenotypic and genetic circulating tumor cells as a biomarker for evaluating the prognosis of RCC.

Authors:  Zhen-Long Wang; Peng Zhang; He-Cheng Li; Xiao-Jie Yang; Ya-Ping Zhang; Zhao-Lun Li; Li Xue; Yu-Quan Xue; Hong-Liang Li; Qi Chen; Tie Chong
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

2.  MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.

Authors:  Roy Nofech-Mozes; Heba W Z Khella; Andreas Scorilas; Leza Youssef; Sergey N Krylov; Evi Lianidou; Konstantinos G Sidiropoulos; Manal Gabril; Andrew Evans; George M Yousef
Journal:  Cancer Med       Date:  2016-02-10       Impact factor: 4.452

3.  Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.

Authors:  Lei Li; Xi Chen; Lu Hao; Qiuyan Chen; Haosheng Liu; Qing Zhou
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

4.  Multi-omics analysis reveals epithelial-mesenchymal transition-related gene FOXM1 as a novel prognostic biomarker in clear cell renal carcinoma.

Authors:  Jing Song; Fangzhou Song; Kun Liu; Wanfeng Zhang; Ruihan Luo; Yongyao Tang; Longke Ran
Journal:  Aging (Albany NY)       Date:  2019-11-19       Impact factor: 5.682

Review 5.  Imaging Characterization of Renal Masses.

Authors:  Carlos Nicolau; Natalie Antunes; Blanca Paño; Carmen Sebastia
Journal:  Medicina (Kaunas)       Date:  2021-01-08       Impact factor: 2.430

6.  Survival in bladder and upper urinary tract cancers in Finland and Sweden through 50 years.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki; Börje Ljungberg; Otto Hemminki
Journal:  PLoS One       Date:  2022-01-04       Impact factor: 3.240

7.  Survival Improvement in Patients with Renal Cell Carcinoma and Disparities between Different Sexes, Races, and Socioeconomic Status: 1977-2016.

Authors:  Dijun Ouyang; Huanhuan Sun; Nan Chen; Yan Yan; Haiqing Ma; Jianchuan Xia
Journal:  J Oncol       Date:  2022-07-30       Impact factor: 4.501

8.  Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden.

Authors:  Kari Hemminki; Asta Försti; Akseli Hemminki; Börje Ljungberg; Otto Hemminki
Journal:  PLoS One       Date:  2021-06-22       Impact factor: 3.240

9.  Decreased capillary density in renal cell carcinoma: Evidence from a case report with micro-computerized tomography.

Authors:  Tzu-Chun Lin; Huey-Yi Chen; You-Rong Yang; Po-Len Liu; Yung-Hsiang Chen; Wen-Chi Chen
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.